Removing the FDA's Boxed Hepatotoxicity Warning and Liver Function Testing Requirement for Ambrisentan.
Feldman WB, Mahesri M, Sarpatwari A, Huybrechts KF, Zhu Y, Hwang CS, Lii J, Lee SB, Kattinakere Sreedhara S, Toyserkani GA, Zhou EH, Zendel L, LaCivita C, Manzo C, Dal Pan GJ, Kesselheim AS, Bykov K.
Feldman WB, et al. Among authors: manzo c.
JAMA Netw Open. 2024 Jul 1;7(7):e2419873. doi: 10.1001/jamanetworkopen.2024.19873.
JAMA Netw Open. 2024.
PMID: 39023895
Free PMC article.